Abstract
SMAD4 constrains progression of Pten-null prostate cancer and serves as a common downstream node of transforming growth factor β (TGFβ) and bone morphogenetic protein (BMP) pathways. Here, we dissected the roles of TGFβ receptor II (TGFBR2) and BMP receptor II (BMPR2) using a Pten-null prostate cancer model. Thesestudies demonstrated that the molecular actions of TGFBR2 result in both SMAD4-dependent constraint of proliferation and SMAD4-independent activation of apoptosis. In contrast, BMPR2 deletion extended survival relative to Pten deletion alone, establishing itspromoting role in BMP6-driven prostate cancer progression. These analyses reveal the complexity ofTGFβ-BMPsignaling and illuminate potential therapeutic targets for prostate cancer.
Original language | English (US) |
---|---|
Pages (from-to) | 2337-2342 |
Number of pages | 6 |
Journal | Genes and Development |
Volume | 31 |
Issue number | 23-24 |
DOIs | |
State | Published - Dec 1 2017 |
Keywords
- BMPR2
- Bone Metastasis
- PTEN
- Prostate cancer
- SMAD4
- TGFBR2
ASJC Scopus subject areas
- Genetics
- Developmental Biology